Cellworks Omics Biology Model (CBM) to Predict Therapy Response and Identify Biomarkers for All-Trans Retinoic Acid (ATRA) Benefit As Addition to Induction Chemotherapy in Adults with Acute Myeloid Leukemia (AML).
Journal of clinical oncology(2021)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined